A detailed history of Russell Investments Group, Ltd. transactions in Biote Corp. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 18,663 shares of BTMD stock, worth $47,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,663
Previous 6,026 209.71%
Holding current value
$47,030
Previous $24,000 129.17%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$2.82 - $4.55 $35,636 - $57,498
12,637 Added 209.71%
18,663 $55,000
Q2 2025

Aug 13, 2025

BUY
$3.25 - $4.28 $16,318 - $21,489
5,021 Added 499.6%
6,026 $24,000
Q1 2025

May 13, 2025

SELL
$3.23 - $6.2 $3,553 - $6,820
-1,100 Reduced 52.26%
1,005 $3,000
Q4 2024

Feb 13, 2025

BUY
$5.04 - $6.93 $10,074 - $13,853
1,999 Added 1885.85%
2,105 $13,000
Q3 2024

Nov 13, 2024

BUY
$5.33 - $8.36 $564 - $886
106 New
106 $0
Q4 2023

Feb 05, 2024

BUY
$4.43 - $5.81 $243 - $319
55 New
55 $0

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $19.1M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.